|
ZNF594 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.640060E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.399400E-01 |
| Normal-vs-Stage2 |
4.386400E-02 |
| Normal-vs-Stage3 |
1.884190E-03 |
| Normal-vs-Stage4 |
3.837200E-03 |
| Stage1-vs-Stage2 |
1.530760E-01 |
| Stage1-vs-Stage3 |
3.058500E-03 |
| Stage1-vs-Stage4 |
1.457980E-02 |
| Stage2-vs-Stage3 |
4.595200E-01 |
| Stage2-vs-Stage4 |
5.581000E-01 |
| Stage3-vs-Stage4 |
8.740000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.325860E-02 |
| Normal-vs-AfricanAmerican |
2.404400E-01 |
| Normal-vs-Asian |
9.505400E-01 |
| Caucasian-vs-AfricanAmerican |
6.239600E-01 |
| Caucasian-vs-Asian |
4.185200E-01 |
| AfricanAmerican-vs-Asian |
5.717000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.015900E-03 |
| Normal-vs-Female |
2.998400E-01 |
| Male-vs-Female |
3.758200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.638600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.968030E-01 |
| Normal-vs-Age(61-80Yrs) |
6.042700E-03 |
| Normal-vs-Age(81-100Yrs) |
3.752100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.194800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.774000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.976200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.106100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.141400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.228400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.169800E-02 |
| Normal-vs-Grade 2 |
4.521800E-01 |
| Normal-vs-Grade 3 |
9.475600E-03 |
| Normal-vs-Grade 4 |
9.24540000002416E-07 |
| Grade 1-vs-Grade 2 |
2.966400E-02 |
| Grade 1-vs-Grade 3 |
9.759900E-04 |
| Grade 1-vs-Grade 4 |
3.32510000000674E-06 |
| Grade 2-vs-Grade 3 |
1.405830E-02 |
| Grade 2-vs-Grade 4 |
4.52139999995715E-06 |
| Grade 3-vs-Grade 4 |
3.183100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.260400E-01 |
| Normal-vs-ccB subtype |
2.38200000000077E-05 |
| ccA subtype-vs-ccB subtype |
5.8563000004952E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.896400E-02 |
| Normal-vs-N1 |
6.076900E-03 |
| N0-vs-N1 |
1.458640E-01 |
|
|
